Answer: Expect a comprehensive lab evaluation, a goals and medication review, a personalized protocol if the stack is appropriate, and ongoing monitoring with dose adjustments based on your response, all coordinated within our supervised peptide program
They followed 173 RA patients with overweight or obesity who were prescribed and actually took a GLP-1 medication (semaglutide or tirzepatide) between 2018 and 2024, and compared them to 42 patients who were prescribed one but never took it
Concluding, our data has shed new insights on the possible involvement of the herb tianma on neuronal functions and its potential effect on signalling molecules critically involved in common neurorestorative processes related to neurodegenerative diseases such as AD, PD or Huntingtons disease (Figure 10)
Age can also play a role, as stomach acid production often decreases in older individuals
Therefore, enhancing bioavailability and stability will be key in the future, although breakthroughs in once-weekly oral GLP-1 drugs are still awaited